{"id":3180,"date":"2025-10-06T05:52:40","date_gmt":"2025-10-06T05:52:40","guid":{"rendered":"https:\/\/genoks.com.tr\/docs\/fragile-x-fmr1-en\/"},"modified":"2026-05-02T05:05:27","modified_gmt":"2026-05-02T05:05:27","password":"","slug":"fragile-x-fmr1-en","status":"publish","type":"docs","link":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/","title":{"rendered":"Fragile X Syndrome (FMR1)"},"content":{"rendered":"<p><!--genoks-intro-en:start--><\/p>\n<p><strong>Fragile X Syndrome (FMR1)<\/strong> is the most common inherited cause of intellectual disability, due to CGG trinucleotide repeat expansion in the FMR1 gene (Xq27.3). Full mutation (&gt;200 repeats) silences FMR1 \u2192 FMRP loss \u2192 classic phenotype. Incidence: ~1\/4000-7000 males. Premutation (55-200) carries FXPOI (women, ~20% before 40y) and FXTAS (\u226550y) risks. Diagnosis: FMR1 CGG repeat analysis (TP-PCR + Southern blot for full mutation).<\/p>\n<p><!--genoks-intro-en:end--><\/p>\n<p style=\"text-align: justify\"><strong>Frajil X Sendromu Nedir ?<\/strong><br \/>\nFragile X, X kromozomunda bulunan FMR1 genindeki mutasyondan kaynaklanan kal\u0131tsal bir bozukluktur. FMR1 (Fragile X Mental Retardation 1) geni beyindeki sinir h\u00fccrelerinde g\u00f6rev alan bir protein sentezler. FMR1 geninde frajilx sendromuna sebep olan mutasyonlar \u00fc\u00e7l\u00fc n\u00fcklotit tekrar art\u0131\u015f\u0131 olarak bilinen \u00f6zel bir mutasyondur, normal ki\u015filerde FMR1 geninde 55 veya daha az CGG tekrar\u0131 olan ki\u015filerde g\u00f6r\u00fclmezken, 200 veya daha fazla CGG tekrar\u0131 olanlarda Fragile X sendromu riski artar.<\/p>\n<p style=\"text-align: justify\">Fragile X sendromu, zeka gerili\u011fi, \u00f6\u011frenme g\u00fc\u00e7l\u00fc\u011f\u00fc, sosyal ve davran\u0131\u015fsal sorunlar, dil ve ileti\u015fim bozukluklar\u0131, hiperaktivite, duygu durum bozukluklar\u0131 ve otizm spektrum bozuklu\u011fu gibi semptomlarla karakterizedir.<\/p>\n<p style=\"text-align: justify\">Fragile X sendromunun kesin bir tedavisi yoktur, ancak semptomlar\u0131 y\u00f6netmek i\u00e7in bir\u00e7ok tedavi se\u00e7ene\u011fi mevcuttur. Bu tedaviler aras\u0131nda erken m\u00fcdahale programlar\u0131, \u00f6zel e\u011fitim, dil ve konu\u015fma terapisi, davran\u0131\u015f terapisi, ila\u00e7lar ve destekleyici terapiler bulunur. Tedaviler, semptomlar\u0131n \u015fiddetini azaltmak, bireylerin i\u015flevselli\u011fini art\u0131rmak ve ya\u015fam kalitesini iyile\u015ftirmek i\u00e7in kullan\u0131l\u0131r.<\/p>\n<table>\n<tbody>\n<tr>\n<td><strong><strong>Gen:<\/strong><\/strong><\/td>\n<td>FMR1<\/td>\n<\/tr>\n<tr>\n<td><strong>Y\u00f6ntem :<\/strong><\/td>\n<td>Tekrar Say\u0131s\u0131<\/td>\n<\/tr>\n<tr>\n<td><strong>Raporlama S\u00fcresi :<\/strong><\/td>\n<td>4 Hafta<\/td>\n<\/tr>\n<tr>\n<td><strong><strong>Prenatal\/ Postnatal:<\/strong><\/strong><\/td>\n<td>Postnatal<\/td>\n<\/tr>\n<tr>\n<td><strong>Gerekli Numune<\/strong>:<\/td>\n<td>EDTA&#8217;l\u0131 Kan (2-4 ml)<\/td>\n<\/tr>\n<tr>\n<td><strong>Saklama \/ Ta\u015f\u0131ma S\u0131cakl\u0131\u011f\u0131:<\/strong><\/td>\n<td>+ 4C\u00b0\/ + 24C\u00b0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>T\u00fcm genetik testlerimiz <strong>&#8220;Hasta Onam Formu&#8221;<\/strong> ve <strong>&#8220;KVKK Formu&#8221;<\/strong>nun imzalanmas\u0131n\u0131n ard\u0131ndan \u00e7al\u0131\u015f\u0131lmaya ba\u015flan\u0131r.<\/p>\n<hr \/>\n<p><strong>Detayl\u0131 Bilgi Almak \u0130\u00e7in Bize Mesaj Atabilirsiniz.<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td>[contact-form-7 id=&#8221;710&#8243; title=&#8221;genetik ba\u015fvuru&#8221;]<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Genoks Genetik Hastal\u0131klar De\u011ferlendirme Merkezi T.C. Sa\u011fl\u0131k Bankanl\u0131\u011f\u0131nca denetlenen ve GHDM-SM\/06.15\/01 ruhsat numaras\u0131 ile hizmet veren sa\u011fl\u0131k kurulu\u015fudur. genoks.com.tr web sayfas\u0131nda bulunan bilgiler, genetik de\u011ferlendirme ve\/veya tan\u0131-te\u015fhis ama\u00e7l\u0131 kullan\u0131lmamal\u0131d\u0131r. T\u00fcm i\u00e7erikler bilgilendirme ama\u00e7l\u0131d\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Fragile X Syndrome (FMR1) is the most common inherited cause of intellectual disability, due to CGG trinucleotide repeat expansion in the FMR1 gene (Xq27.3). Full mutation (&gt;200 repeats) silences FMR1 \u2192 FMRP loss \u2192 classic phenotype. Incidence: ~1\/4000-7000 males. Premutation<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"doc_category":[204],"doc_tag":[102,103,104],"class_list":["post-3180","docs","type-docs","status-publish","hentry","doc_category-genoks-gdhm-genetic-tests","doc_tag-fmr1","doc_tag-frajil-x","doc_tag-frajil-x-sendromu"],"aioseo_notices":[],"year_month":"2026-05","word_count":352,"total_views":0,"reactions":{"happy":0,"normal":0,"sad":0},"author_info":{"name":"admin","author_nicename":"admin","author_url":"https:\/\/genoks.com.tr\/en\/author\/admin\/"},"doc_category_info":[{"term_name":"Genoks GDHM Genetic Tests","term_url":"https:\/\/genoks.com.tr\/en\/docs-category\/genoks-gdhm-genetic-tests\/"}],"doc_tag_info":[{"term_name":"FMR1","term_url":"https:\/\/genoks.com.tr\/docs-tag\/fmr1\/"},{"term_name":"Frajil X","term_url":"https:\/\/genoks.com.tr\/docs-tag\/frajil-x\/"},{"term_name":"Frajil X Sendromu","term_url":"https:\/\/genoks.com.tr\/docs-tag\/frajil-x-sendromu\/"}],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 4.9.5.2 - aioseo.com -->\n\t<meta name=\"description\" content=\"Fragile X Syndrome (FMR1) is the most common inherited cause of intellectual disability, due to CGG trinucleotide repeat expansion in the FMR1 gene (Xq27.3). Full mutation (&gt;200 repeats) silences FMR1 \u2192 FMRP loss \u2192 classic phenotype. Incidence: ~1\/4000-7000 males. Premutation (55-200) carries FXPOI (women, ~20% before 40y) and FXTAS (\u226550y) risks. Diagnosis: FMR1 CGG repeat\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 4.9.5.2\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services - Shedding Light on Your Genes!\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Fragile X Syndrome (FMR1) - Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services\" \/>\n\t\t<meta property=\"og:description\" content=\"Fragile X Syndrome (FMR1) is the most common inherited cause of intellectual disability, due to CGG trinucleotide repeat expansion in the FMR1 gene (Xq27.3). Full mutation (&gt;200 repeats) silences FMR1 \u2192 FMRP loss \u2192 classic phenotype. Incidence: ~1\/4000-7000 males. Premutation (55-200) carries FXPOI (women, ~20% before 40y) and FXTAS (\u226550y) risks. Diagnosis: FMR1 CGG repeat\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-10-06T05:52:40+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-05-02T05:05:27+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/GenoksGHTM\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@Genoks_GHTM\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Fragile X Syndrome (FMR1) - Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Fragile X Syndrome (FMR1) is the most common inherited cause of intellectual disability, due to CGG trinucleotide repeat expansion in the FMR1 gene (Xq27.3). Full mutation (&gt;200 repeats) silences FMR1 \u2192 FMRP loss \u2192 classic phenotype. Incidence: ~1\/4000-7000 males. Premutation (55-200) carries FXPOI (women, ~20% before 40y) and FXTAS (\u226550y) risks. Diagnosis: FMR1 CGG repeat\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@Genoks_GHTM\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs\\\/fragile-x-fmr1-en\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/Genoks\\\/#listItem\",\"name\":\"Dok\\u00fcmanlar\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/Genoks\\\/#listItem\",\"position\":2,\"name\":\"Dok\\u00fcmanlar\",\"item\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/Genoks\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs-category\\\/genoks-gdhm-genetic-tests\\\/#listItem\",\"name\":\"Genoks GDHM Genetic Tests\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs-category\\\/genoks-gdhm-genetic-tests\\\/#listItem\",\"position\":3,\"name\":\"Genoks GDHM Genetic Tests\",\"item\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs-category\\\/genoks-gdhm-genetic-tests\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs\\\/fragile-x-fmr1-en\\\/#listItem\",\"name\":\"Fragile X Syndrome (FMR1)\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/Genoks\\\/#listItem\",\"name\":\"Dok\\u00fcmanlar\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs\\\/fragile-x-fmr1-en\\\/#listItem\",\"position\":4,\"name\":\"Fragile X Syndrome (FMR1)\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs-category\\\/genoks-gdhm-genetic-tests\\\/#listItem\",\"name\":\"Genoks GDHM Genetic Tests\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/#organization\",\"name\":\"Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services\",\"description\":\"Shedding Light on Your Genes!\",\"url\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/\",\"telephone\":\"+904448732\",\"foundingDate\":\"2014-12-01\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"value\":160},\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/genoks.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/genoks.svg\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs\\\/fragile-x-fmr1-en\\\/#organizationLogo\",\"caption\":\"RapidNIPT testi ile yap\\u0131lan NIPT taramas\\u0131 sayesinde gebelikte 90'dan fazla kromozomal hastal\\u0131k risksiz ve erken d\\u00f6nemde tespit edilir.\"},\"image\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs\\\/fragile-x-fmr1-en\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/GenoksGHTM\",\"https:\\\/\\\/x.com\\\/Genoks_GHTM\",\"https:\\\/\\\/www.instagram.com\\\/genoks_ghtm\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/genoks\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/74da4ab1a4df3c3e843b41fd6523384c13b4e218e11eb9518da4421619941871?s=96&d=mm&r=g\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs\\\/fragile-x-fmr1-en\\\/#webpage\",\"url\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs\\\/fragile-x-fmr1-en\\\/\",\"name\":\"Fragile X Syndrome (FMR1) - Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services\",\"description\":\"Fragile X Syndrome (FMR1) is the most common inherited cause of intellectual disability, due to CGG trinucleotide repeat expansion in the FMR1 gene (Xq27.3). Full mutation (>200 repeats) silences FMR1 \\u2192 FMRP loss \\u2192 classic phenotype. Incidence: ~1\\\/4000-7000 males. Premutation (55-200) carries FXPOI (women, ~20% before 40y) and FXTAS (\\u226550y) risks. Diagnosis: FMR1 CGG repeat\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/docs\\\/fragile-x-fmr1-en\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/author\\\/admin\\\/#author\"},\"datePublished\":\"2025-10-06T05:52:40+00:00\",\"dateModified\":\"2026-05-02T05:05:27+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/\",\"name\":\"Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services\",\"description\":\"Shedding Light on Your Genes!\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Fragile X Syndrome (FMR1) - Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services<\/title>\n\n","aioseo_head_json":{"title":"Fragile X Syndrome (FMR1) - Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services","description":"Fragile X Syndrome (FMR1) is the most common inherited cause of intellectual disability, due to CGG trinucleotide repeat expansion in the FMR1 gene (Xq27.3). Full mutation (>200 repeats) silences FMR1 \u2192 FMRP loss \u2192 classic phenotype. Incidence: ~1\/4000-7000 males. Premutation (55-200) carries FXPOI (women, ~20% before 40y) and FXTAS (\u226550y) risks. Diagnosis: FMR1 CGG repeat","canonical_url":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/genoks.com.tr\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/en\/Genoks\/#listItem","name":"Dok\u00fcmanlar"}},{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/en\/Genoks\/#listItem","position":2,"name":"Dok\u00fcmanlar","item":"https:\/\/genoks.com.tr\/en\/Genoks\/","nextItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/en\/docs-category\/genoks-gdhm-genetic-tests\/#listItem","name":"Genoks GDHM Genetic Tests"},"previousItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/en\/docs-category\/genoks-gdhm-genetic-tests\/#listItem","position":3,"name":"Genoks GDHM Genetic Tests","item":"https:\/\/genoks.com.tr\/en\/docs-category\/genoks-gdhm-genetic-tests\/","nextItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/#listItem","name":"Fragile X Syndrome (FMR1)"},"previousItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/en\/Genoks\/#listItem","name":"Dok\u00fcmanlar"}},{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/#listItem","position":4,"name":"Fragile X Syndrome (FMR1)","previousItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/en\/docs-category\/genoks-gdhm-genetic-tests\/#listItem","name":"Genoks GDHM Genetic Tests"}}]},{"@type":"Organization","@id":"https:\/\/genoks.com.tr\/en\/#organization","name":"Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services","description":"Shedding Light on Your Genes!","url":"https:\/\/genoks.com.tr\/en\/","telephone":"+904448732","foundingDate":"2014-12-01","numberOfEmployees":{"@type":"QuantitativeValue","value":160},"logo":{"@type":"ImageObject","url":"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg","@id":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/#organizationLogo","caption":"RapidNIPT testi ile yap\u0131lan NIPT taramas\u0131 sayesinde gebelikte 90'dan fazla kromozomal hastal\u0131k risksiz ve erken d\u00f6nemde tespit edilir."},"image":{"@id":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/GenoksGHTM","https:\/\/x.com\/Genoks_GHTM","https:\/\/www.instagram.com\/genoks_ghtm\/","https:\/\/www.linkedin.com\/in\/genoks\/"]},{"@type":"Person","@id":"https:\/\/genoks.com.tr\/en\/author\/admin\/#author","url":"https:\/\/genoks.com.tr\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","url":"https:\/\/secure.gravatar.com\/avatar\/74da4ab1a4df3c3e843b41fd6523384c13b4e218e11eb9518da4421619941871?s=96&d=mm&r=g"}},{"@type":"WebPage","@id":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/#webpage","url":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/","name":"Fragile X Syndrome (FMR1) - Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services","description":"Fragile X Syndrome (FMR1) is the most common inherited cause of intellectual disability, due to CGG trinucleotide repeat expansion in the FMR1 gene (Xq27.3). Full mutation (>200 repeats) silences FMR1 \u2192 FMRP loss \u2192 classic phenotype. Incidence: ~1\/4000-7000 males. Premutation (55-200) carries FXPOI (women, ~20% before 40y) and FXTAS (\u226550y) risks. Diagnosis: FMR1 CGG repeat","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/genoks.com.tr\/en\/#website"},"breadcrumb":{"@id":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/#breadcrumblist"},"author":{"@id":"https:\/\/genoks.com.tr\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/genoks.com.tr\/en\/author\/admin\/#author"},"datePublished":"2025-10-06T05:52:40+00:00","dateModified":"2026-05-02T05:05:27+00:00"},{"@type":"WebSite","@id":"https:\/\/genoks.com.tr\/en\/#website","url":"https:\/\/genoks.com.tr\/en\/","name":"Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services","description":"Shedding Light on Your Genes!","inLanguage":"en-US","publisher":{"@id":"https:\/\/genoks.com.tr\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services - Shedding Light on Your Genes!","og:type":"article","og:title":"Fragile X Syndrome (FMR1) - Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services","og:description":"Fragile X Syndrome (FMR1) is the most common inherited cause of intellectual disability, due to CGG trinucleotide repeat expansion in the FMR1 gene (Xq27.3). Full mutation (&gt;200 repeats) silences FMR1 \u2192 FMRP loss \u2192 classic phenotype. Incidence: ~1\/4000-7000 males. Premutation (55-200) carries FXPOI (women, ~20% before 40y) and FXTAS (\u226550y) risks. Diagnosis: FMR1 CGG repeat","og:url":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/","og:image":"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg","og:image:secure_url":"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg","article:published_time":"2025-10-06T05:52:40+00:00","article:modified_time":"2026-05-02T05:05:27+00:00","article:publisher":"https:\/\/www.facebook.com\/GenoksGHTM","twitter:card":"summary_large_image","twitter:site":"@Genoks_GHTM","twitter:title":"Fragile X Syndrome (FMR1) - Genoks Genetics | NIPT, Carrier Screening, Oncogenetics and WES Services","twitter:description":"Fragile X Syndrome (FMR1) is the most common inherited cause of intellectual disability, due to CGG trinucleotide repeat expansion in the FMR1 gene (Xq27.3). Full mutation (&gt;200 repeats) silences FMR1 \u2192 FMRP loss \u2192 classic phenotype. Incidence: ~1\/4000-7000 males. Premutation (55-200) carries FXPOI (women, ~20% before 40y) and FXTAS (\u226550y) risks. Diagnosis: FMR1 CGG repeat","twitter:creator":"@Genoks_GHTM","twitter:image":"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg"},"aioseo_meta_data":{"post_id":"3180","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"seo_analyzer_scan_date":"2026-05-02 05:20:56","breadcrumb_settings":null,"limit_modified_date":false,"reviewed_by":null,"open_ai":null,"ai":null,"created":"2026-05-01 14:34:31","updated":"2026-05-02 05:28:01"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/genoks.com.tr\/en\/\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/genoks.com.tr\/en\/Genoks\/\" title=\"Dok\u00fcmanlar\">Dok\u00fcmanlar<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/genoks.com.tr\/en\/docs-category\/genoks-gdhm-genetic-tests\/\" title=\"Genoks GDHM Genetic Tests\">Genoks GDHM Genetic Tests<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tFragile X Syndrome (FMR1)\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/genoks.com.tr\/en\/"},{"label":"Dok\u00fcmanlar","link":"https:\/\/genoks.com.tr\/en\/Genoks\/"},{"label":"Genoks GDHM Genetic Tests","link":"https:\/\/genoks.com.tr\/en\/docs-category\/genoks-gdhm-genetic-tests\/"},{"label":"Fragile X Syndrome (FMR1)","link":"https:\/\/genoks.com.tr\/en\/docs\/fragile-x-fmr1-en\/"}],"_links":{"self":[{"href":"https:\/\/genoks.com.tr\/en\/wp-json\/wp\/v2\/docs\/3180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genoks.com.tr\/en\/wp-json\/wp\/v2\/docs"}],"about":[{"href":"https:\/\/genoks.com.tr\/en\/wp-json\/wp\/v2\/types\/docs"}],"author":[{"embeddable":true,"href":"https:\/\/genoks.com.tr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genoks.com.tr\/en\/wp-json\/wp\/v2\/comments?post=3180"}],"version-history":[{"count":1,"href":"https:\/\/genoks.com.tr\/en\/wp-json\/wp\/v2\/docs\/3180\/revisions"}],"predecessor-version":[{"id":3488,"href":"https:\/\/genoks.com.tr\/en\/wp-json\/wp\/v2\/docs\/3180\/revisions\/3488"}],"wp:attachment":[{"href":"https:\/\/genoks.com.tr\/en\/wp-json\/wp\/v2\/media?parent=3180"}],"wp:term":[{"taxonomy":"doc_category","embeddable":true,"href":"https:\/\/genoks.com.tr\/en\/wp-json\/wp\/v2\/doc_category?post=3180"},{"taxonomy":"doc_tag","embeddable":true,"href":"https:\/\/genoks.com.tr\/en\/wp-json\/wp\/v2\/doc_tag?post=3180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}